281 related articles for article (PubMed ID: 30041029)
1. From 'fixed dose combinations' to 'a dynamic dose combiner': 3D printed bi-layer antihypertensive tablets.
Sadia M; Isreb A; Abbadi I; Isreb M; Aziz D; Selo A; Timmins P; Alhnan MA
Eur J Pharm Sci; 2018 Oct; 123():484-494. PubMed ID: 30041029
[TBL] [Abstract][Full Text] [Related]
2. 'Temporary Plasticiser': A novel solution to fabricate 3D printed patient-centred cardiovascular 'Polypill' architectures.
Pereira BC; Isreb A; Forbes RT; Dores F; Habashy R; Petit JB; Alhnan MA; Oga EF
Eur J Pharm Biopharm; 2019 Feb; 135():94-103. PubMed ID: 30579852
[TBL] [Abstract][Full Text] [Related]
3. Continuous manufacturing and analytical characterization of fixed-dose, multilayer orodispersible films.
Thabet Y; Lunter D; Breitkreutz J
Eur J Pharm Sci; 2018 May; 117():236-244. PubMed ID: 29499348
[TBL] [Abstract][Full Text] [Related]
4. A 3D printed bilayer oral solid dosage form combining metformin for prolonged and glimepiride for immediate drug delivery.
Gioumouxouzis CI; Baklavaridis A; Katsamenis OL; Markopoulou CK; Bouropoulos N; Tzetzis D; Fatouros DG
Eur J Pharm Sci; 2018 Jul; 120():40-52. PubMed ID: 29678613
[TBL] [Abstract][Full Text] [Related]
5. A Lower Temperature FDM 3D Printing for the Manufacture of Patient-Specific Immediate Release Tablets.
Okwuosa TC; Stefaniak D; Arafat B; Isreb A; Wan KW; Alhnan MA
Pharm Res; 2016 Nov; 33(11):2704-12. PubMed ID: 27506424
[TBL] [Abstract][Full Text] [Related]
6. Fabrication of a shell-core fixed-dose combination tablet using fused deposition modeling 3D printing.
Alzahrani A; Narala S; Adel Ali Youssef A; Nyavanandi D; Bandari S; Mandati P; Almotairy A; Almutairi M; Repka M
Eur J Pharm Biopharm; 2022 Aug; 177():211-223. PubMed ID: 35835328
[TBL] [Abstract][Full Text] [Related]
7. Adaptation of pharmaceutical excipients to FDM 3D printing for the fabrication of patient-tailored immediate release tablets.
Sadia M; Sośnicka A; Arafat B; Isreb A; Ahmed W; Kelarakis A; Alhnan MA
Int J Pharm; 2016 Nov; 513(1-2):659-668. PubMed ID: 27640246
[TBL] [Abstract][Full Text] [Related]
8. Mass-customization of oral tablets via the combination of 3D printing and injection molding.
Fuenmayor E; O'Donnell C; Gately N; Doran P; Devine DM; Lyons JG; McConville C; Major I
Int J Pharm; 2019 Oct; 569():118611. PubMed ID: 31415874
[TBL] [Abstract][Full Text] [Related]
9. Continuous inkjet printing of enalapril maleate onto orodispersible film formulations.
Thabet Y; Lunter D; Breitkreutz J
Int J Pharm; 2018 Jul; 546(1-2):180-187. PubMed ID: 29753906
[TBL] [Abstract][Full Text] [Related]
10. Amorphous solid dispersion of a binary formulation with felodipine and HPMC for 3D printed floating tablets.
Mora-Castaño G; Millán-Jiménez M; Niederquell A; Schönenberger M; Shojaie F; Kuentz M; Caraballo I
Int J Pharm; 2024 Jun; 658():124215. PubMed ID: 38740104
[TBL] [Abstract][Full Text] [Related]
11. A comparative study between hot-melt extrusion and spray-drying for the manufacture of anti-hypertension compatible monolithic fixed-dose combination products.
Kelleher JF; Gilvary GC; Madi AM; Jones DS; Li S; Tian Y; Almajaan A; Senta-Loys Z; Andrews GP; Healy AM
Int J Pharm; 2018 Jul; 545(1-2):183-196. PubMed ID: 29730176
[TBL] [Abstract][Full Text] [Related]
12. Low temperature fused deposition modeling (FDM) 3D printing of thermolabile drugs.
Kollamaram G; Croker DM; Walker GM; Goyanes A; Basit AW; Gaisford S
Int J Pharm; 2018 Jul; 545(1-2):144-152. PubMed ID: 29705104
[TBL] [Abstract][Full Text] [Related]
13. Fabricating a Shell-Core Delayed Release Tablet Using Dual FDM 3D Printing for Patient-Centred Therapy.
Okwuosa TC; Pereira BC; Arafat B; Cieszynska M; Isreb A; Alhnan MA
Pharm Res; 2017 Feb; 34(2):427-437. PubMed ID: 27943014
[TBL] [Abstract][Full Text] [Related]
14. 3D printing of pharmaceutical oral solid dosage forms by fused deposition: The enhancement of printability using plasticised HPMCAS.
Oladeji S; Mohylyuk V; Jones DS; Andrews GP
Int J Pharm; 2022 Mar; 616():121553. PubMed ID: 35131354
[TBL] [Abstract][Full Text] [Related]
15. A flexible-dose dispenser for immediate and extended release 3D printed tablets.
Pietrzak K; Isreb A; Alhnan MA
Eur J Pharm Biopharm; 2015 Oct; 96():380-7. PubMed ID: 26277660
[TBL] [Abstract][Full Text] [Related]
16. Influence of pH modifiers on the dissolution and stability of hydrochlorothiazide in the bi- and three-layer tablets.
Blatnik SU; Dreu R; Srčič S
Acta Pharm; 2015 Dec; 65(4):383-97. PubMed ID: 26677896
[TBL] [Abstract][Full Text] [Related]
17. Performance and paroxetine stability in tablets manufactured by fused deposition modelling-based 3D printing.
Figueiredo S; Fernandes AI; Carvalho FG; Pinto JF
J Pharm Pharmacol; 2022 Jan; 74(1):67-76. PubMed ID: 34591102
[TBL] [Abstract][Full Text] [Related]
18. How to Obtain the Maximum Properties Flexibility of 3D Printed Ketoprofen Tablets Using Only One Drug-Loaded Filament?
Pyteraf J; Jamróz W; Kurek M; Szafraniec-Szczęsny J; Kramarczyk D; Jurkiewicz K; Knapik-Kowalczuk J; Tarasiuk J; Wroński S; Paluch M; Jachowicz R
Molecules; 2021 May; 26(11):. PubMed ID: 34067434
[TBL] [Abstract][Full Text] [Related]
19. Preparation and In vitro Evaluation of FDM 3D-Printed Ellipsoid-Shaped Gastric Floating Tablets with Low Infill Percentages.
Chen D; Xu XY; Li R; Zang GA; Zhang Y; Wang MR; Xiong MF; Xu JR; Wang T; Fu H; Hu Q; Wu B; Yan GR; Fan TY
AAPS PharmSciTech; 2019 Nov; 21(1):6. PubMed ID: 31754916
[TBL] [Abstract][Full Text] [Related]
20. Formulation of 3D Printed Tablet for Rapid Drug Release by Fused Deposition Modeling: Screening Polymers for Drug Release, Drug-Polymer Miscibility and Printability.
Solanki NG; Tahsin M; Shah AV; Serajuddin ATM
J Pharm Sci; 2018 Jan; 107(1):390-401. PubMed ID: 29066279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
